First-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging

R Laforest, A Ghai, TJ Fraum, R Oyama… - Journal of Nuclear …, 2023 - Soc Nuclear Med
There remains an unmet need for molecularly targeted imaging agents for multiple myeloma
(MM). The integrin very late antigen 4 (VLA4), is differentially expressed in malignant MM …

Post‐treatment 18F‐fludeoxyglocuse‐positron emission tomography in human papillomavirus‐associated oropharyngeal cancer

ZY Liu, D Khoo, G Hartel, C Punyadeera… - Head & …, 2023 - Wiley Online Library
Background Human papillomavirus association has changed the landscape of treatment for
oropharyngeal squamous cell carcinoma; it remains to be seen whether current post …

18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus–Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified …

RM Subramaniam, L DeMora, M Yao… - Journal of Nuclear …, 2023 - Soc Nuclear Med
The purpose of this study was to determine the negative predictive value (NPV) of a 12-to 14-
wk posttreatment PET/CT for 2-y progression-free survival (PFS) and locoregional control …

[HTML][HTML] Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®

V Liapis, W Tieu, SE Rudd, PS Donnelly… - EJNMMI radiopharmacy …, 2020 - Springer
Purpose The chimeric monoclonal antibody (mAb) chDAB4 (APOMAB®) targets the Lupus
associated (La)/Sjögren Syndrome-B (SSB) antigen, which is over-expressed in tumors but …

[HTML][HTML] Performance of NI-RADS on CECT Alone to Predict Recurrent Head and Neck Squamous Cell Carcinoma after Chemoradiotherapy: Added Value of RECIST …

I Kumar, SO Reza, S Choudhary… - Indian Journal of …, 2022 - thieme-connect.com
Background The Head and Neck Imaging Reporting and Data System (NI-RADS) is a
standardized reporting format for the categorization of the degree of suspicion for recurrent …

It's about quality, not quantity: Qualitative FDG PET/CT criteria for therapy response assessment in clinical practice

KP Banks, JG Peacock, M Gusman… - American Journal of …, 2020 - Am Roentgen Ray Soc
OBJECTIVE. FDG PET/CT has emerged as an effective tool for the timely accurate
assessment of how tumors respond to therapy. To standardize interpretation and reporting …

[HTML][HTML] Positron emission tomographic imaging of tumor cell death using Zirconium-89-labeled APOMAB® following cisplatin chemotherapy in lung and ovarian …

V Liapis, W Tieu, NL Wittwer, T Gargett… - Molecular Imaging and …, 2021 - Springer
Purpose Early detection of tumor treatment responses represents an unmet clinical need
with no approved noninvasive methods. DAB4, or its chimeric derivative, chDAB4 …

18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified …

J Geiger, L Mell, S Seaward, W Thorstad… - Journal of Nuclear …, 2023 - escholarship.org
The purpose of this study was to determine the negative predictive value (NPV) of a 12-to 14-
wk posttreatment PET/CT for 2-y progression-free survival (PFS) and locoregional control …

Qualitative and quantitative methods in post-chemoradiation PET for head and neck cancer

JD Oldan, BM Beaty, VL Jewells… - Nuclear Medicine …, 2022 - journals.lww.com
Objective The aim of this study was to determine whether quantitative methods could aid in
the evaluation of post-treatment head and neck scans, particularly taking human …

Positron Emission Tomography and Molecular Imaging of Head and Neck Malignancies

F Moradi - Current Radiology Reports, 2020 - Springer
Abstract Purpose of Review Metabolic reprogramming and avid fluorodeoxyglucose (FDG)
uptake in locally advanced head and neck squamous cell carcinomas and other cancers of …